SGH
Sivik Global Healthcare Portfolio holdings
AUM
$224M
This Quarter Return
+18%
1 Year Return
+5.3%
3 Year Return
+45.33%
5 Year Return
+103.79%
10 Year Return
+430.94%
AUM
$271M
AUM Growth
+$271M
(+46%)
Cap. Flow
+$68.2M
Cap. Flow
% of AUM
25.15%
Top 10 Holdings %
Top 10 Hldgs %
30.71%
Holding
68
New
19
Increased
25
Reduced
11
Closed
9
Top Buys
| 1 |
Novo Nordisk
NVO
|
$7.06M |
| 2 |
ALXN
Alexion Pharmaceuticals Inc
ALXN
|
$6.08M |
| 3 |
Sanofi
SNY
|
$5.76M |
| 4 |
CELG
Celgene Corp
CELG
|
$5.66M |
| 5 |
GWPH
GW Pharmaceuticals Plc American Depositary Shares
GWPH
|
$4.21M |
Top Sells
| 1 |
Cigna
CI
|
$7.6M |
| 2 |
UnitedHealth
UNH
|
$6.98M |
| 3 |
SPDR S&P Biotech ETF
XBI
|
$5.38M |
| 4 |
Zimmer Biomet
ZBH
|
$2.07M |
| 5 |
Intuitive Surgical
ISRG
|
$2M |
Sector Composition
| 1 | Healthcare | 92.98% |
| 2 | Energy | 1.43% |
| 3 | Utilities | 0.64% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
51
Sarepta Therapeutics
SRPT
$1.78B
| $1.79M | 0.66% |
15,000
-5,000
| -25% | -$596K |
|
|
EAS
52
DELISTED
ENERGY EAST CORP (HOLD CO)
EAS
| $1.73M | 0.64% |
+20,000
| New | +$1.73M |
|
53
Agios Pharmaceuticals
AGIO
$2.19B
| $1.69M | 0.62% |
25,000
+10,000
| +67% | +$674K |
|
|
SAGE
54
DELISTED
Sage Therapeutics
SAGE
| $1.59M | 0.59% |
10,000
| – | – |
|
55
Puma Biotechnology
PBYI
$254M
| $1.55M | 0.57% |
+40,000
| New | +$1.55M |
|
56
DexCom
DXCM
$29.5B
| $1.49M | 0.55% |
12,500
+5,000
| +67% | +$596K |
|
|
AKRX
57
DELISTED
Akorn, Inc.
AKRX
| $1.29M | 0.47% |
+365,700
| New | +$1.29M |
|
|
SGEN
58
DELISTED
Seagen Inc. Common Stock
SGEN
| $732K | 0.27% |
+10,000
| New | +$732K |
|
|
59
Cigna
CI
$80.3B
| – | – |
-40,000
| Closed | -$7.6M |
|
60
Cencora
COR
$56.5B
| – | – |
-10,000
| Closed | -$744K |
|
61
Haemonetics
HAE
$2.63B
| – | – |
-5,000
| Closed | -$500K |
|
62
McKesson
MCK
$85.4B
| – | – |
-15,000
| Closed | -$1.66M |
|
63
Moderna
MRNA
$9.37B
| – | – |
-25,000
| Closed | -$382K |
|
|
64
UnitedHealth
UNH
$281B
| – | – |
-28,000
| Closed | -$6.98M |
|
|
65
SPDR S&P Biotech ETF
XBI
$5.07B
| – | – |
-75,000
| Closed | -$5.38M |
|
|
66
Zimmer Biomet
ZBH
$21B
| – | – |
-20,000
| Closed | -$2.07M |
|
|
LOXO
67
DELISTED
Loxo Oncology, Inc
LOXO
| – | – |
-10,000
| Closed | -$1.4M |
|